{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:41:46Z","timestamp":1785526906505,"version":"3.56.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s11060-026-05674-5","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T10:01:03Z","timestamp":1782381663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated serum and tissue NMR metabolomics with correlation analysis reveals metabolic alterations in gliomas"],"prefix":"10.1007","volume":"178","author":[{"given":"Aanchal","family":"Datta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awadhesh Kumar","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikash","family":"Baishya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuntal Kanti","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"5674_CR1","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/JAMA.2013.280319","volume":"310","author":"A Omuro","year":"2013","unstructured":"Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310:1842\u20131850. https:\/\/doi.org\/10.1001\/JAMA.2013.280319","journal-title":"JAMA"},{"key":"5674_CR2","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.3390\/CANCERS14102412","volume":"14","author":"S Grochans","year":"2022","unstructured":"Grochans S, Cybulska AM, Simi\u0144ska D, Korbecki J, Kojder K, Chlubek D, Baranowska-Bosiacka I (2022) Epidemiology of Glioblastoma. Multiforme\u2013Literature Rev Cancers 2022 14:14, 2412. Page 2412https:\/\/doi.org\/10.3390\/CANCERS14102412","journal-title":"Multiforme\u2013Literature Rev Cancers 2022"},{"key":"5674_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/S40336-022-00489-6\/METRICS","volume":"10","author":"A Pellerino","year":"2022","unstructured":"Pellerino A, Caccese M, Padovan M, Cerretti G, Lombardi G (2022) Epidemiology, risk factors, and prognostic factors of gliomas. Clin Transl Imaging 10:467\u2013475. https:\/\/doi.org\/10.1007\/S40336-022-00489-6\/METRICS","journal-title":"Clin Transl Imaging"},{"key":"5674_CR4","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMOA043330;PAGE:STRING:ARTICLE\/CHAPTER","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, van den Mason WP, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMOA043330;PAGE:STRING:ARTICLE\/CHAPTER","journal-title":"N Engl J Med"},{"key":"5674_CR5","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3390\/BRAINSCI13111536","volume":"13","author":"RS Angom","year":"2023","unstructured":"Angom RS, Nakka NMR, Bhattacharya S (2023) Advances in Glioblastoma Therapy: An Update on Current Approaches. Brain Sci 13:1536. https:\/\/doi.org\/10.3390\/BRAINSCI13111536","journal-title":"Brain Sci"},{"key":"5674_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/NRD728","volume":"1","author":"JK Nicholson","year":"2002","unstructured":"Nicholson JK, Connelly J, Lindon JC, Holmes E (2002) Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1:153\u2013161. https:\/\/doi.org\/10.1038\/NRD728","journal-title":"Nat Rev Drug Discov"},{"key":"5674_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/METABO9070123","volume":"9","author":"AH Emwas","year":"2019","unstructured":"Emwas AH, Roy R, McKay RT, Tenori L, Saccenti E, Nagana Gowda GA, Raftery D, Alahmari F, Jaremko L, Jaremko M, Wishart DS (2019) NMR Spectroscopy for Metabolomics Research. Metabolites 9:123. https:\/\/doi.org\/10.3390\/METABO9070123","journal-title":"Metabolites"},{"key":"5674_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-3-030-51652-9_2","volume":"1280","author":"GA Nagana Gowda","year":"2021","unstructured":"Nagana Gowda GA, Raftery D (2021) NMR-Based Metabolomics. Adv Exp Med Biol 1280:19\u201337. https:\/\/doi.org\/10.1007\/978-3-030-51652-9_2","journal-title":"Adv Exp Med Biol"},{"key":"5674_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/J.JMR.2019.07.013","volume":"306","author":"DS Wishart","year":"2019","unstructured":"Wishart DS (2019) NMR metabolomics: A look ahead. J Magn Reson 306:155\u2013161. https:\/\/doi.org\/10.1016\/J.JMR.2019.07.013","journal-title":"J Magn Reson"},{"key":"5674_CR10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/NM.2682","volume":"18","author":"C Choi","year":"2012","unstructured":"Choi C, Ganji SK, DeBerardinis RJ, Hatanpaa KJ, Rakheja D, Kovacs Z, Yang XL, Mashimo T, Raisanen JM, Marin-Valencia I, Pascual JM, Madden CJ, Mickey BE, Malloy CR, Bachoo RM, Maher EA (2012) 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nat Med 18:624\u2013629. https:\/\/doi.org\/10.1038\/NM.2682","journal-title":"Nat Med"},{"key":"5674_CR11","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1002\/IUB.2149","volume":"71","author":"E Baranovi\u010dov\u00e1","year":"2019","unstructured":"Baranovi\u010dov\u00e1 E, Galanda T, Galanda M, Hatok J, Kolarovszki B, Richterov\u00e1 R, Ra\u010day P (2019) Metabolomic profiling of blood plasma in patients with primary brain tumours: Basal plasma metabolites correlated with tumour grade and plasma biomarker analysis predicts feasibility of the successful statistical discrimination from healthy subjects - a preliminary study. IUBMB Life 71:1994\u20132002. https:\/\/doi.org\/10.1002\/IUB.2149","journal-title":"IUBMB Life"},{"key":"5674_CR12","doi-asserted-by":"publisher","unstructured":"Wang DH, Fujita Y, Dono A, Rodriguez Armendariz AG, Shah M, Putluri N, Pichardo-Rojas PS, Patel CB, Zhu JJ, Huse JT, Kerrigan P, Lang BC, Esquenazi FF, Ballester Y (2024) The genomic alterations in glioblastoma influence the levels of CSF metabolites. Acta Neuropathol Commun 12. https:\/\/doi.org\/10.1186\/S40478-024-01722-1","DOI":"10.1186\/S40478-024-01722-1"},{"key":"5674_CR13","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1021\/ACS.JPROTEOME.0C00697","volume":"20","author":"Y Shi","year":"2021","unstructured":"Shi Y, Ding D, Liu L, Li Z, Zuo L, Zhou L, Du Q, Jing Z, Zhang X, Sun Z (2021) Integrative Analysis of Metabolomic and Transcriptomic Data Reveals Metabolic Alterations in Glioma Patients. J Proteome Res 20:2206\u20132215. https:\/\/doi.org\/10.1021\/ACS.JPROTEOME.0C00697","journal-title":"J Proteome Res"},{"key":"5674_CR14","doi-asserted-by":"publisher","unstructured":"Gilard V, Ferey J, Marguet F, Fontanilles M, Ducatez F, Pilon C, Lesueur C, Pereira T, Basset C, Schmitz-Afonso I, Di Fior\u00e9 F, Laquerri\u00e8re A, Afonso C, Derrey S, Marret S, Bekri S, Tebani A (2021) Integrative metabolomics reveals deep tissue and systemic metabolic remodeling in glioblastoma. Cancers (Basel) 13:5157. https:\/\/doi.org\/10.3390\/CANCERS13205157","DOI":"10.3390\/CANCERS13205157"},{"key":"5674_CR15","doi-asserted-by":"publisher","first-page":"260670","DOI":"10.3389\/FCELL.2017.00043\/FULL","volume":"5","author":"M Strickland","year":"2017","unstructured":"Strickland M, Stoll EA (2017) Metabolic reprogramming in glioma. Front Cell Dev Biol 5:260670. https:\/\/doi.org\/10.3389\/FCELL.2017.00043\/FULL","journal-title":"Front Cell Dev Biol"},{"key":"5674_CR16","doi-asserted-by":"publisher","unstructured":"Tiwari V, Daoud EV, Hatanpaa KJ, Gao A, Zhang S, An Z, Ganji SK, Raisanen JM, Lewis CM, Askari P, Baxter J, Levy M, Dimitrov I, Thomas BP, Pinho MC, Madden CJ, Pan E, Patel TR, DeBerardinis RJ, Sherry AD, Mickey BE, Malloy CR, Maher EA, Choi C (2020) Glycine by MR spectroscopy is an imaging biomarker of glioma aggressiveness. Neuro Oncol 22:1018\u20131029. https:\/\/doi.org\/10.1093\/neuonc\/noaa034","DOI":"10.1093\/neuonc\/noaa034"},{"key":"5674_CR17","doi-asserted-by":"publisher","first-page":"e3747","DOI":"10.1002\/NBM.3747","volume":"30","author":"V Tiwari","year":"2017","unstructured":"Tiwari V, An Z, Ganji SK, Baxter J, Patel TR, Pan E, Mickey BE, Maher EA, Pinho MC, Choi C (2017) Measurement of glycine in healthy and tumorous brain by triple-refocusing MRS at 3 T in vivo. NMR Biomed 30:e3747. https:\/\/doi.org\/10.1002\/NBM.3747","journal-title":"NMR Biomed"},{"key":"5674_CR18","doi-asserted-by":"publisher","unstructured":"Yu Z, Kastenm\u00fcller G, He Y, Belcredi P, M\u00f6ller G, Prehn C, Mendes J, Wahl S, Roemisch-Margl W, Ceglarek U, Polonikov A, Dahmen N, Prokisch H, Xie L, Li Y, Wichmann HE, Peters A, Kronenberg F, Suhre K, Adamski J, Illig T, Wang-Sattler R (2011) Differences between human plasma and serum metabolite profiles. PLoS One 6:e21230. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0021230","DOI":"10.1371\/JOURNAL.PONE.0021230"},{"key":"5674_CR19","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/METABO5030502","volume":"5","author":"L M\u00f6r\u00e9n","year":"2015","unstructured":"M\u00f6r\u00e9n L, Tommy Bergenheim A, Ghasimi S, Br\u00e4nnstr\u00f6m T, Johansson M, Antti H (2015) Metabolomic Screening of Tumor Tissue and Serum in Glioma Patients Reveals Diagnostic and Prognostic Information. Metabolites 5:502. https:\/\/doi.org\/10.3390\/METABO5030502","journal-title":"Metabolites"},{"key":"5674_CR20","doi-asserted-by":"publisher","first-page":"70366","DOI":"10.18632\/ONCOTARGET.19705","volume":"8","author":"J Huang","year":"2017","unstructured":"Huang J, Weinstein SJ, Kitahara CM, Karoly ED, Sampson JN, Albanes D (2017) A prospective study of serum metabolites and glioma risk. Oncotarget 8:70366. https:\/\/doi.org\/10.18632\/ONCOTARGET.19705","journal-title":"Oncotarget"},{"key":"5674_CR21","doi-asserted-by":"publisher","first-page":"34190","DOI":"10.1021\/ACSOMEGA.5C00296","volume":"10","author":"M Zou","year":"2025","unstructured":"Zou M, Guo X, Xie W, Jiang J, Li W, Kang X (2025) Identification of Malignant Progression of Gliomas through Metabolomics of Cerebrospinal Fluid and Serum. ACS Omega 10:34190\u201334203. https:\/\/doi.org\/10.1021\/ACSOMEGA.5C00296","journal-title":"ACS Omega"},{"key":"5674_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/S13014-016-0626-6","volume":"11","author":"L M\u00f6r\u00e9n","year":"2016","unstructured":"M\u00f6r\u00e9n L, Wibom C, Bergstr\u00f6m P, Johansson M, Antti H, Bergenheim AT (2016) Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas. Radiat Oncol 11:51. https:\/\/doi.org\/10.1186\/S13014-016-0626-6","journal-title":"Radiat Oncol"},{"key":"5674_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/J.JOCN.2019.07.078","volume":"68","author":"JE Lee","year":"2019","unstructured":"Lee JE, Jeun SS, Kim SH, Yoo CY, Baek HM, Yang SH (2019) Metabolic profiling of human gliomas assessed with NMR. J Clin Neurosci 68:275\u2013280. https:\/\/doi.org\/10.1016\/J.JOCN.2019.07.078","journal-title":"J Clin Neurosci"},{"key":"5674_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/METABO10120478","volume":"10","author":"D Yu","year":"2020","unstructured":"Yu D, Xuan Q, Zhang C, Hu C, Li Y, Zhao X, Liu S, Ren F, Zhang Y, Zhou L, Xu G (2020) Metabolic Alterations Related to Glioma Grading Based on Metabolomics and Lipidomics Analyses. Metabolites 10:1\u201311. https:\/\/doi.org\/10.3390\/METABO10120478","journal-title":"Metabolites"},{"key":"5674_CR25","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1002\/ELPS.202100130","volume":"42","author":"J Ma","year":"2021","unstructured":"Ma J, Li T, Chen H, Wang C, Wang H, Li Q (2021) Lipidomic analysis and diagnosis of glioblastoma multiforme with rapid evaporative ionization mass spectrometry. Electrophoresis 42:1965\u20131973. https:\/\/doi.org\/10.1002\/ELPS.202100130","journal-title":"Electrophoresis"},{"key":"5674_CR26","doi-asserted-by":"publisher","unstructured":"Ekici S, Risk BB, Neill SG, Shu HK, Fleischer CC (2020) Characterization of dysregulated glutamine metabolism in human glioma tissue with 1H NMR. Sci Rep 10:20435. https:\/\/doi.org\/10.1038\/s41598-020-76982-7","DOI":"10.1038\/s41598-020-76982-7"},{"key":"5674_CR27","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/NBM.2794","volume":"25","author":"EA Maher","year":"2012","unstructured":"Maher EA, Marin-Valencia I, Bachoo RM, Mashimo T, Raisanen J, Hatanpaa KJ, Jindal A, Jeffrey FM, Choi C, Madden C, Mathews D, Pascual JM, Mickey BE, Malloy CR, Deberardinis RJ (2012) Metabolism of [U-13\u00a0C]glucose in human brain tumors in vivo. NMR Biomed 25:1234\u20131244. https:\/\/doi.org\/10.1002\/NBM.2794","journal-title":"NMR Biomed"},{"key":"5674_CR28","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.cell.2014.11.025","volume":"159","author":"T Mashimo","year":"2014","unstructured":"Mashimo T, Pichumani K, Vemireddy V, Hatanpaa KJ, Singh DK, Sirasanagandla S, Nannepaga S, Piccirillo SG, Kovacs Z, Foong C, Huang Z, Barnett S, Mickey BE, Deberardinis RJ, Tu BP, Maher EA, Bachoo RM (2014) Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell 159:1603\u20131614. https:\/\/doi.org\/10.1016\/j.cell.2014.11.025","journal-title":"Cell"},{"key":"5674_CR29","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1093\/ANNONC\/MDX169","volume":"28","author":"MA Qazi","year":"2017","unstructured":"Qazi MA, Vora P, Venugopal C, Sidhu SS, Moffat J, Swanton C, Singh SK (2017) Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma. Ann Oncol 28:1448\u20131456. https:\/\/doi.org\/10.1093\/ANNONC\/MDX169","journal-title":"Ann Oncol"},{"key":"5674_CR30","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2008.08.026","volume":"134","author":"E Holmes","year":"2008","unstructured":"Holmes E, Wilson ID, Nicholson JK (2008) Metabolic Phenotyping in Health and Disease. Cell 134:714\u2013717. https:\/\/doi.org\/10.1016\/j.cell.2008.08.026","journal-title":"Cell"},{"key":"5674_CR31","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/nprot.2007.376","volume":"2","author":"O Beckonert","year":"2007","unstructured":"Beckonert O, Keun HC, Ebbels TMD, Bundy J, Holmes E, Lindon JC, Nicholson JK (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2:2692\u20132703. https:\/\/doi.org\/10.1038\/nprot.2007.376","journal-title":"Nat Protoc"},{"key":"5674_CR32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/J.AB.2007.10.002","volume":"372","author":"H Wu","year":"2008","unstructured":"Wu H, Southam AD, Hines A, Viant MR (2008) High-throughput tissue extraction protocol for NMR- and MS-based metabolomics. Anal Biochem 372:204\u2013212. https:\/\/doi.org\/10.1016\/J.AB.2007.10.002","journal-title":"Anal Biochem"},{"key":"5674_CR33","doi-asserted-by":"publisher","unstructured":"Liang J, Lv X, Lu C, Ye X, Chen X, Fu J, Luo C, Zhao Y (2020) Prognostic factors of patients with gliomas\u2014an analysis on 335 patients with glioblastoma and other forms of gliomas. BMC Cancer 20:35. https:\/\/doi.org\/10.1186\/S12885-019-6511-6","DOI":"10.1186\/S12885-019-6511-6"},{"key":"5674_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12113349","volume":"12","author":"P Jonsson","year":"2020","unstructured":"Jonsson P, Antti H, Sp\u00e4th F, Melin B, Bj\u00f6rkblom B (2020) Identification of Pre-Diagnostic Metabolic Patterns for Glioma Using Subset Analysis of Matched Repeated Time Points. Cancers (Basel) 12:1\u201320. https:\/\/doi.org\/10.3390\/cancers12113349","journal-title":"Cancers (Basel)"},{"key":"5674_CR35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.4103\/0028-3886.177606","volume":"64","author":"A Kelimu","year":"2016","unstructured":"Kelimu A, Xie R, Zhang K, Zhuang Z, Mamtimin B, Sheyhidin I (2016) Metabonomic signature analysis in plasma samples of glioma patients based on 1H-nuclear magnetic resonance spectroscopy. Neurol India 64:246\u2013251. https:\/\/doi.org\/10.4103\/0028-3886.177606","journal-title":"Neurol India"},{"key":"5674_CR36","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.3390\/IJMS23074022","volume":"23","author":"A Dimou","year":"2022","unstructured":"Dimou A, Tsimihodimos V, Bairaktari E (2022) The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain \u03b1-Keto Acid Dehydrogenase (BCKD), in Human Pathophysiology. Int J Mol Sci 23:4022. https:\/\/doi.org\/10.3390\/IJMS23074022","journal-title":"Int J Mol Sci"},{"key":"5674_CR37","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/nm.3217","volume":"19","author":"M T\u00f6njes","year":"2013","unstructured":"T\u00f6njes M, Barbus S, Park YJ, Wang W, Schlotter M, Lindroth AM, Pleier SV, Bai AHC, Karra D, Piro RM, Felsberg J, Addington A, Lemke D, Weibrecht I, Hovestadt V, Rolli CG, Campos B, Turcan S, Sturm D, Witt H, Chan TA, Herold-Mende C, Kemkemer R, K\u00f6nig R, Schmidt K, Hull WE, Pfister SM, Jugold M, Hutson SM, Plass C, Okun JG, Reifenberger G, Lichter P, Radlwimmer B (2013) BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. Nat Med 19:901\u2013908. https:\/\/doi.org\/10.1038\/nm.3217","journal-title":"Nat Med"},{"key":"5674_CR38","doi-asserted-by":"publisher","unstructured":"Lu Z, Sun GF, He KY, Zhang Z, Han XH, Qu XH, Wan DF, Yao D, Tou FF, Han XJ, Wang T (2024) Targeted inhibition of branched-chain amino acid metabolism drives apoptosis of glioblastoma by facilitating ubiquitin degradation of Mfn2 and oxidative stress. Biochim Biophys Acta Mol Basis Dis 1870:167220. https:\/\/doi.org\/10.1016\/J.BBADIS.2024.167220","DOI":"10.1016\/J.BBADIS.2024.167220"},{"issue":"1","key":"5674_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41420-020-00341-8","volume":"6","author":"L Burke","year":"2020","unstructured":"Burke L, Guterman I, Palacios Gallego R, Britton RG, Burschowsky D, Tufarelli C, Rufini A (2020) The Janus-like role of proline metabolism in cancer. Cell Death Discovery 2020 6(1):6, 104. https:\/\/doi.org\/10.1038\/s41420-020-00341-8","journal-title":"Cell Death Discovery 2020"},{"key":"5674_CR40","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1089\/ARS.2017.7350","volume":"30","author":"JM Phang","year":"2018","unstructured":"Phang JM (2018) Proline Metabolism in Cell Regulation and Cancer Biology: Recent Advances and Hypotheses. Antioxid Redox Signal 30:635. https:\/\/doi.org\/10.1089\/ARS.2017.7350","journal-title":"Antioxid Redox Signal"},{"key":"5674_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/FONC.2012.00060","volume":"2","author":"JM Phang","year":"2012","unstructured":"Phang JM, Liu W, Hancock C, Christian KJ (2012) The Proline Regulatory Axis and Cancer. Front Oncol 2:60. https:\/\/doi.org\/10.3389\/FONC.2012.00060","journal-title":"Front Oncol"},{"key":"5674_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/S12964-020-00539-4\/FIGURES\/8","volume":"18","author":"C Lu","year":"2020","unstructured":"Lu C, Fang S, Weng Q, Lv X, Meng M, Zhu J, Zheng L, Hu Y, Gao Y, Wu X, Mao J, Tang B, Zhao Z, Huang L, Ji J (2020) Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma. Cell Communication Signal 18:97. https:\/\/doi.org\/10.1186\/S12964-020-00539-4\/FIGURES\/8","journal-title":"Cell Communication Signal"},{"key":"5674_CR43","doi-asserted-by":"publisher","unstructured":"Shin E, Koo JS (2021) Glucose metabolism and glucose transporters in breast cancer. Front Cell Dev Biol 9:728759. https:\/\/doi.org\/10.3389\/FCELL.2021.728759","DOI":"10.3389\/FCELL.2021.728759"},{"key":"5674_CR44","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/J.TIBS.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW (2016) The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem Sci 41:211. https:\/\/doi.org\/10.1016\/J.TIBS.2015.12.001","journal-title":"Trends Biochem Sci"},{"key":"5674_CR45","doi-asserted-by":"publisher","first-page":"134963","DOI":"10.3389\/FONC.2015.00055\/BIBTEX","volume":"5","author":"NR Parker","year":"2015","unstructured":"Parker NR, Khong P, Parkinson JF, Howell VM, Wheeler HR (2015) Molecular heterogeneity in glioblastoma: Potential clinical implications. Front Oncol 5:134963. https:\/\/doi.org\/10.3389\/FONC.2015.00055\/BIBTEX","journal-title":"Front Oncol"},{"key":"5674_CR46","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/S11060-023-04521-1","volume":"165","author":"BB Yavuz","year":"2023","unstructured":"Yavuz BB, Kilinc F, Kanyilmaz G, Aktan M (2023) Pyruvate kinase M2 (PKM-2) expression and prognostic significance in glioblastoma patients. J Neurooncol 165:527\u2013533. https:\/\/doi.org\/10.1007\/S11060-023-04521-1","journal-title":"J Neurooncol"},{"key":"5674_CR47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.14791\/BTRT.2013.1.2.57","volume":"1","author":"MK Jha","year":"2013","unstructured":"Jha MK, Suk K (2013) Pyruvate Dehydrogenase Kinase as a Potential Therapeutic Target for Malignant Gliomas. Brain Tumor Res Treat 1:57. https:\/\/doi.org\/10.14791\/BTRT.2013.1.2.57","journal-title":"Brain Tumor Res Treat"},{"key":"5674_CR48","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1038\/BJC.2017.118","volume":"116","author":"AC Newman","year":"2017","unstructured":"Newman AC, Maddocks ODK (2017) One-carbon metabolism in cancer. Br J Cancer 116:1499\u20131504. https:\/\/doi.org\/10.1038\/BJC.2017.118","journal-title":"Br J Cancer"},{"key":"5674_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/S13046-025-03361-3","volume":"44","author":"X Liu","year":"2025","unstructured":"Liu X, Liu B, Wang J, Liu H, Wu J, Qi Y, Liu Y, Zhu H, Li C, Yang L, Song J, Yao G, Tian W, Zhao K, Han L, Shu K, Zhang S, Man J, You C, Huang H, Li R (2025) PHGDH activation fuels glioblastoma progression and radioresistance via serine synthesis pathway. J Exp Clin Cancer Res 44:99. https:\/\/doi.org\/10.1186\/S13046-025-03361-3","journal-title":"J Exp Clin Cancer Res"},{"key":"5674_CR50","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.2147\/OTT.S130409","volume":"10","author":"M Wu","year":"2017","unstructured":"Wu M, Wanggou S, Li X, Liu Q, Xie Y (2017) Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas. Onco Targets Ther 10:3781. https:\/\/doi.org\/10.2147\/OTT.S130409","journal-title":"Onco Targets Ther"},{"key":"5674_CR51","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/NEUONC\/NOAA034","volume":"22","author":"T Vivek","year":"2020","unstructured":"Vivek T, Elena VD, Kimmo JH, Ang G, Song Z, Zhongxu A, Sandeep KG, Jack MR, Cheryl ML, Pegah A, Jeannie B, Michael L, Ivan D, Binu PT, Marco CP, Christopher JM, Edward P, Toral RP, Ralph JDB, Sherry AD, Bruce EM, Craig RM, Elizabeth AM, Changho C (2020) Glycine by MR spectroscopy is an imaging biomarker of glioma aggressiveness. Neuro Oncol 22:1018\u20131029. https:\/\/doi.org\/10.1093\/NEUONC\/NOAA034","journal-title":"Neuro Oncol"},{"key":"5674_CR52","doi-asserted-by":"publisher","unstructured":"Yadav P, Vengoji R, Jain M, Batra SK, Shonka N (2024) Pathophysiological role of histamine signaling and its implications in glioblastoma. Biochim Biophys Acta Rev Cancer 1879:189146. https:\/\/doi.org\/10.1016\/J.BBCAN.2024.189146","DOI":"10.1016\/J.BBCAN.2024.189146"},{"key":"5674_CR53","doi-asserted-by":"publisher","first-page":"17107","DOI":"10.18632\/ONCOTARGET.3672","volume":"6","author":"J-J Lin","year":"2015","unstructured":"Lin J-J, Zhao T-Z, Cai W-K, Yang Y-X, Sun C, Zhang Z, Xu Y-Q, Chang T, Li Z-Y, Lin J-J, Zhao T-Z, Cai W-K, Yang Y-X, Sun C, Zhang Z, Xu Y-Q, Chang T, Li Z-Y (2015) Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition. Oncotarget 6:17107\u201317120. https:\/\/doi.org\/10.18632\/ONCOTARGET.3672","journal-title":"Oncotarget"},{"key":"5674_CR54","unstructured":"Study Details | NCT03145012 | Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity | ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT03145012"},{"key":"5674_CR55","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/NM.2453","volume":"17","author":"SC Buckingham","year":"2011","unstructured":"Buckingham SC, Campbell SL, Haas BR, Montana V, Robel S, Ogunrinu T, Sontheimer H (2011) Glutamate release by primary brain tumors induces epileptic activity. Nat Med 17:1269\u20131274. https:\/\/doi.org\/10.1038\/NM.2453","journal-title":"Nat Med"},{"key":"5674_CR56","doi-asserted-by":"publisher","first-page":"260","DOI":"10.7555\/JBR.34.20190037","volume":"34","author":"H Yi","year":"2020","unstructured":"Yi H, Talmon G, Wang J (2020) Glutamate in cancers: from metabolism to signaling. J Biomed Res 34:260. https:\/\/doi.org\/10.7555\/JBR.34.20190037","journal-title":"J Biomed Res"},{"key":"5674_CR57","doi-asserted-by":"publisher","first-page":"10767","DOI":"10.1523\/JNEUROSCI.19-24-10767.1999","volume":"19","author":"ZC Ye","year":"1999","unstructured":"Ye ZC, Rothstein JD, Sontheimer H (1999) Compromised Glutamate Transport in Human Glioma Cells: Reduction\u2013Mislocalization of Sodium-Dependent Glutamate Transporters and Enhanced Activity of Cystine\u2013Glutamate Exchange. J Neurosci 19:10767. https:\/\/doi.org\/10.1523\/JNEUROSCI.19-24-10767.1999","journal-title":"J Neurosci"},{"key":"5674_CR58","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/S00018-013-1521-Z","volume":"71","author":"SM Robert","year":"2013","unstructured":"Robert SM, Sontheimer H (2013) Glutamate transporters in the biology of malignant gliomas. Cell Mol Life Sci 71:1839. https:\/\/doi.org\/10.1007\/S00018-013-1521-Z","journal-title":"Cell Mol Life Sci"},{"key":"5674_CR59","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/S12276-020-00504-8;SUBJMETA","volume":"52","author":"HC Yoo","year":"2020","unstructured":"Yoo HC, Yu YC, Sung Y, Han JM (2020) Glutamine reliance in cell metabolism. Exp Mol Med 52:1496\u20131516. https:\/\/doi.org\/10.1038\/S12276-020-00504-8;SUBJMETA","journal-title":"Exp Mol Med"},{"key":"5674_CR60","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/S00018-020-03483-1","volume":"78","author":"B Zhang","year":"2020","unstructured":"Zhang B, Chen Y, Shi X, Zhou M, Bao L, Hatanpaa KJ, Patel T, DeBerardinis RJ, Wang Y, Luo W (2020) Regulation of branched-chain amino acid metabolism by hypoxia-inducible factor in glioblastoma. Cell Mol Life Sci 78:195. https:\/\/doi.org\/10.1007\/S00018-020-03483-1","journal-title":"Cell Mol Life Sci"},{"key":"5674_CR61","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/NRC3557;SUBJMETA","volume":"13","author":"JW Locasale","year":"2013","unstructured":"Locasale JW (2013) Serine, glycine and one-carbon units: Cancer metabolism in full circle. Nat Rev Cancer 13:572\u2013583. https:\/\/doi.org\/10.1038\/NRC3557;SUBJMETA","journal-title":"Nat Rev Cancer"},{"key":"5674_CR62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/S12276-020-0375-3;SUBJMETA","volume":"52","author":"EL Lieu","year":"2020","unstructured":"Lieu EL, Nguyen T, Rhyne S, Kim J (2020) Amino acids in cancer. Exp Mol Med 52:15\u201330. https:\/\/doi.org\/10.1038\/S12276-020-0375-3;SUBJMETA","journal-title":"Exp Mol Med"},{"key":"5674_CR63","doi-asserted-by":"publisher","unstructured":"Dong Y, Tu R, Liu H, Qing G (2020) Regulation of cancer cell metabolism: oncogenic MYC in the driver\u2019s seat. Signal Transduct Target Ther 5:124. https:\/\/doi.org\/10.1038\/s41392-020-00235-2","DOI":"10.1038\/s41392-020-00235-2"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05674-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05674-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05674-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:06:04Z","timestamp":1785521164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05674-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5674"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05674-5","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was ethically approved by the institutional ethics committee, SGPGIMS, Lucknow, India (\n                      2020-237-MCh-EXP-29\n                      , dated 08-09-2020). The procedures involving human participants were in accordance to the ethical norms of the committee as well as the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"was taken from all the study participants or their first degree relative for study participation. The participants also provided consent for publication.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declaration"}}],"article-number":"77"}}